|
|
||||||||
|
FIGURE 4. Change in visual analog score (A), medication index (B), and daily activity (C) in placebo group and rhenium group during follow-up. VAS = visual analog score; 0 = time at baseline.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |